STEATOHEPATITIS-LIVER CANCER MODEL ANIMAL

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120117671A1
SERIAL NO

13319851

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Fatty liver was induced by administering agents for inducing organ inflammation to experimental animals to evoke insulin resistance and by rearing them with high-fat diets. As a result, steatohepatitis was successfully induced in the animals. The animals show pathological findings similar to those of humans. By using these model animals, substances for treating or preventing diseases can be efficiently screened and the efficacy of medicinal substances can be effectively evaluated.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STELIC INSTITUTE OF REGENERATIVE MEDICINE STELIC INSTITUTE & COTOKYO 106-0044

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fujii, Masato Tokyo, JP 54 338
Yoneyama, Hiroyuki Tokyo, JP 177 1018

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation